Intermediate stage treatment: Is TACE enough?
Liver Int
.
2018 Jan;38(1):187.
doi: 10.1111/liv.13598.
Epub 2017 Oct 23.
Authors
Xavier Adhoute
1
,
Guillaume Penaranda
2
,
Jean Luc Raoul
3
,
Marc Bourlière
1
Affiliations
1
Department of Hepato-Gastroenterology, Hôpital Saint-Joseph, Marseille, France.
2
AlphaBio Laboratory, Marseille, France.
3
Department of Hepato-Gastroenterology and Digestive Oncology, Institut Paoli-Calmette, Marseille, France.
PMID:
28952186
DOI:
10.1111/liv.13598
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic*
Humans
Liver Neoplasms
Neoplasm Staging
Treatment Outcome